← brief for 2026-08-10 · Slowing decline

Calcineurin inhibitor versus mycophenolate mofetil along with rituximab in non-genetic calcineurin inhibitor resistant steroid resistant nephrotic syndrome: retrospective observation from western India

Paper C Peer reviewed Observational

Key takeaways

This study compared two treatments in people whose nephrotic syndrome did not get better with steroids. One group got a drug called a calcineurin inhibitor; the other got mycophenolate plus rituximab. It looked back at past patient records in western India, so it shows a link, not proof, and cannot say for sure which treatment is better because patients were not randomly assigned.

Who did this work

Disha Kalpit Bhatt (Institute of Transplantation Sciences) · Shahenaz Kapadia (Institute of Transplantation Sciences) · Anshuman Saha (Institute of Transplantation Sciences) · Kinnari Vala (Institute of Transplantation Sciences)

Source

Indexed paper · OpenAlex — CKD concept sweep (DB seed + weekly delta) · 2026-08-04
https://doi.org/10.21203/rs.3.rs-10511566/v1